Name (Synonyms) | Correlation | |
---|---|---|
drug1935 | Proxalutamide Wiki | 1.00 |
drug799 | Dutasteride Wiki | 1.00 |
drug1270 | Ivermectin Wiki | 0.24 |
drug262 | Azithromycin Wiki | 0.17 |
Name (Synonyms) | Correlation | |
---|---|---|
D011470 | Prostatic Hyperplasia NIH | 1.00 |
D006965 | Hyperplasia NIH | 1.00 |
D000505 | Alopecia NIH | 0.71 |
D045169 | Severe Acute Respiratory Syndrome NIH | 0.05 |
D018352 | Coronavirus Infections NIH | 0.04 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0008711 | Benign prostatic hyperplasia HPO | 1.00 |
HP:0002293 | Alopecia of scalp HPO | 0.71 |
There is one clinical trial.
Biological collection (blood sample) associated with clinical data from Covid-19 patients
Description: Clinical aggravation markers (admission in intensive care)
Measure: Phenotype/genotype correlation research modulating the severity of Covid-19 disease Time: Anytime in the period of 10 yearsDescription: Severity at the Covid-19 Lung Scanner
Measure: Phenotype/transcriptomic correlation research modulating the severity of Covid-19 disease Time: Anytime in the period of 10 yearsDescription: Severity at the Covid-19 Lung Scanner
Measure: Phenotype/biomarker correlation research modulating the severity of Covid-19 disease Time: Anytime in the period of 10 yearsDescription: Evolution of scanographic lesions or pulmonary ultrasound
Measure: Development of clinical-biological scores in the severity of Covid-19 disease Time: Anytime in the period of 10 yearsDescription: Evolution of scanographic lesions or pulmonary ultrasound
Measure: Development of predictive imaging scores in the severity of Covid-19 disease Time: Anytime in the period of 10 yearsDescription: Duration of oxygen therapy, artificial ventilation
Measure: Identification of pathophysiological pathways to susceptibility to Covid-19 disease Time: Anytime in the period of 10 yearsDescription: Genome sequencing
Measure: Identification of genetic markers for treatment response Time: Anytime in the period of 10 yearsDescription: Sequencing transcriptome
Measure: Identification of transcriptomic markers for treatment response Time: Anytime in the period of 10 yearsDescription: Proteomic sequencing
Measure: Identification of proteomic for treatment response Time: Anytime in the period of 10 years